SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-006120 to Sanara MedTech Inc. (SMTI) (CIK 0000714256) (SMTI)

Sanara MedTech Inc. (SMTI) (CIK 0000714256)
Date: May 28, 2024 · CIK: 0000714256 · Accession: 0000000000-24-006120

AI Filing Summary & Sentiment

File numbers found in text: 333-279592

Date
May 28, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Sanara MedTech Inc. (SMTI) (CIK 0000714256)

Letter

United States securities and exchange commission logo May 28, 2024 Michael Neil Chief Financial Officer Sanara MedTech Inc. 1200 Summit Ave, Suite 414 Fort Worth , Texas 76102 Re:Sanara MedTech Inc. Registration Statement on Form S-3 Filed May 21, 2024 File No. 333-279592 Dear Michael Neil: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at 202-551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
United States securities and exchange commission logo
May 28, 2024
Michael Neil
Chief Financial Officer
Sanara MedTech Inc.
1200 Summit Ave, Suite 414
Fort Worth , Texas 76102
Re:Sanara MedTech Inc.
Registration Statement on Form S-3
Filed May 21, 2024
File No. 333-279592
Dear Michael Neil:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Abby Adams at 202-551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services